Universal flu vaccine: mRNA-based candidate enters clinical trial | Hacker News Reader

Universal flu vaccine: mRNA-based candidate enters clinical trial

arstechnica.com

Interesting that this vaccine was developed by the NIH itself, rather than Moderna or Pfizer.

Such a thing, if it works, would be hugely lucrative. Any idea who would manufacture it, and who would profit from it?

  'Cost to the economy of influenza (flu)'

(2018) Economic burden of seasonal influenza in the United States : https://pubmed.ncbi.nlm.nih.gov/29801998/